Menu
GeneBe

OTUD4

OTU deubiquitinase 4, the group of OTU domain containing

Basic information

Region (hg38): 4:145110837-145180589

Links

ENSG00000164164NCBI:54726OMIM:611744HGNC:24949Uniprot:Q01804AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OTUD4 gene.

  • Inborn genetic diseases (29 variants)
  • not provided (4 variants)
  • not specified (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OTUD4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
missense
29
clinvar
29
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 29 3 0

Variants in OTUD4

This is a list of pathogenic ClinVar variants found in the OTUD4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-145111042-G-A not specified Uncertain significance (Feb 22, 2023)2487252
4-145111062-T-G Malignant tumor of prostate Uncertain significance (-)161505
4-145112254-G-A Benign (Apr 04, 2018)714248
4-145119934-A-G not specified Uncertain significance (Jun 06, 2023)2517572
4-145120042-A-T not specified Uncertain significance (Aug 13, 2021)2244611
4-145123265-C-T Benign (Apr 04, 2018)769637
4-145123482-A-G not specified Uncertain significance (Dec 22, 2023)3129315
4-145137460-C-T not specified Uncertain significance (Jan 03, 2022)2265196
4-145137534-G-A not specified Uncertain significance (Oct 20, 2023)3207382
4-145137569-C-T not specified Uncertain significance (Dec 08, 2023)3207381
4-145137683-G-C not specified Uncertain significance (Dec 28, 2023)3207380
4-145137717-T-C not specified Uncertain significance (Dec 01, 2022)2331623
4-145137745-G-A Likely benign (Sep 01, 2022)2655109
4-145137772-A-T not specified Conflicting classifications of pathogenicity (Jul 01, 2023)211809
4-145137776-G-A not specified Uncertain significance (Oct 04, 2022)2316584
4-145137776-G-T not specified Uncertain significance (Feb 06, 2024)3207379
4-145137782-G-C Amenorrhea Uncertain significance (Mar 08, 2021)1344745
4-145137899-C-T not specified Uncertain significance (Apr 28, 2023)2522195
4-145137960-G-T not specified Uncertain significance (Nov 18, 2022)2375363
4-145137969-G-A not specified Uncertain significance (Oct 20, 2021)2392269
4-145138037-G-A not specified Uncertain significance (Aug 10, 2021)2386072
4-145138068-A-C not specified Uncertain significance (Sep 23, 2023)3207378
4-145138126-G-C Likely benign (Mar 01, 2023)2655110
4-145138241-T-C not specified Uncertain significance (Nov 30, 2022)2329883
4-145138258-C-A not specified Uncertain significance (Nov 18, 2022)2327986

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OTUD4protein_codingprotein_codingENST00000454497 2069324
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.00002911257240231257470.0000915
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.564345360.8100.00002626814
Missense in Polyphen113162.660.69472171
Synonymous-0.01151891891.000.000009222021
Loss of Function6.19655.90.1070.00000308690

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003760.000376
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.00009250.0000924
European (Non-Finnish)0.00003520.0000352
Middle Eastern0.0001090.000109
South Asian0.000.00
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Deubiquitinase which hydrolyzes the isopeptide bond between the ubiquitin C-terminus and the lysine epsilon-amino group of the target protein (PubMed:23827681, PubMed:25944111, PubMed:29395066). May negatively regulate inflammatory and pathogen recognition signaling in innate immune response. Upon phosphorylation at Ser-202 and Ser-204 residues, via IL-1 receptor and Toll-like receptor signaling pathway, specifically deubiquitinates 'Lys-63'-polyubiquitinated MYD88 adapter protein triggering down-regulation of NF-kappa-B-dependent transcription of inflammatory mediators (PubMed:29395066). Independently of the catalytic activity, acts as a scaffold for alternative deubiquitinases to assemble specific deubiquitinase-substrate complexes. Associates with USP7 and USP9X deubiquitinases to stabilize alkylation repair enzyme ALKBH3, thereby promoting the repair of alkylated DNA lesions (PubMed:25944111). {ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:25944111, ECO:0000269|PubMed:29395066}.;

Recessive Scores

pRec
0.129

Intolerance Scores

loftool
0.381
rvis_EVS
-0.99
rvis_percentile_EVS
8.56

Haploinsufficiency Scores

pHI
0.462
hipred
Y
hipred_score
0.501
ghis
0.586

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.942

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Otud4
Phenotype

Zebrafish Information Network

Gene name
otud4
Affected structure
post-vent region
Phenotype tag
abnormal
Phenotype quality
curled

Gene ontology

Biological process
protein deubiquitination;negative regulation of toll-like receptor signaling pathway;innate immune response;protein K63-linked deubiquitination;protein K48-linked deubiquitination;positive regulation of DNA demethylation;regulation of protein K48-linked deubiquitination;negative regulation of interleukin-1-mediated signaling pathway
Cellular component
nucleus;cytoplasm
Molecular function
RNA binding;thiol-dependent ubiquitin-specific protease activity;protein binding;protein-containing complex scaffold activity;Lys63-specific deubiquitinase activity